Iran succeeds in producing “recombinant flu vaccine”

Last year, seasonal flu vaccines were supplied from other countries, but an Iranian knowledge-based company produced the vaccine using a recombinant protein, and after clinical studies, intends to produce 3 to 5 million doses.According to the social group of Tasnim news agency ; “After clinical studies, we intend to produce 3 to 5 million doses and meet the needs of the country,” said the CEO of a knowledge-based company that produces seasonal flu vaccines.
See the link below for more information

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

17 − four =